AAAAAA
Results:
1-14
|
Results: 14
Authors:
Noldus, J
Michl, U
Graefen, M
Haese, A
Hammerer, P
Fernandez, S
Huland, H
Citation: J. Noldus et al., Nerve-sparing radical retropublic prostatectomy. Outcome analysis based onpatient questionnaires, UROLOGE A, 40(2), 2001, pp. 102
Authors:
Haese, A
Graefen, M
Steuber, T
Becker, C
Pettersson, K
Piironen, T
Noldus, J
Huland, H
Lilja, H
Citation: A. Haese et al., Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ-confined from locally-advanced prostate cancer in total PSA-levels below 10 ng/ml, PROSTATE, 49(2), 2001, pp. 101-109
Authors:
Graefen, M
Haese, A
Pichlmeier, U
Hammerer, PG
Noldus, J
Butz, K
Erbersdobler, A
Henke, RP
Michl, U
Fernandez, S
Huland, H
Citation: M. Graefen et al., A validated strategy for side specific prediction of organ confined prostate cancer: A tool to select for nerve sparing radical prostatectomy, J UROL, 165(3), 2001, pp. 857-863
Authors:
Reek, C
Graefen, M
Erbersdobler, A
Haese, A
Citation: C. Reek et al., Mucin-positive adenocarcinoma of the urachus. A case report and review of the literature, UROLOGE A, 39(6), 2000, pp. 572-575
Authors:
Graefen, M
Hammerer, P
Haese, A
Huland, H
Citation: M. Graefen et al., Therapy options for hormon-refractory carcinoma of the prostate, UROLOGE A, 39(3), 2000, pp. 267-273
Authors:
Graefen, M
Hammerer, P
Noldus, J
Haese, A
Pichelmeier, U
Erbersdobler, A
Henke, H
Conrad, S
Fernandez, S
Huland, H
Citation: M. Graefen et al., Prognostic markers for prostate cancer, UROLOGE A, 39(1), 2000, pp. 14-21
Authors:
Noldus, J
Graefen, M
Haese, A
Henke, RP
Hammerer, P
Huland, H
Citation: J. Noldus et al., Stage migration in clinically localized prostate cancer, EUR UROL, 38(1), 2000, pp. 74-78
Authors:
Hammerer, P
Graefen, M
Henke, RP
Haese, A
Palisaar, J
Huland, E
Huland, H
Citation: P. Hammerer et al., Analysis of molecular isoforms of PSA and their ratios in men with PSA-relapse after radical prostatectomy, ANTICANC R, 20(6D), 2000, pp. 5253-5255
Authors:
Hautmann, S
Huland, E
Grupp, C
Haese, A
Huland, H
Citation: S. Hautmann et al., Super-sensitive prostate-specific antigen (PSA) in serum of women with benign breast disease or breast cancer, ANTICANC R, 20(3B), 2000, pp. 2151-2154
Authors:
Haese, A
Becker, C
Noldus, J
Graefen, M
Huland, E
Huland, H
Lilja, H
Citation: A. Haese et al., Human glandular kallikrein 2: A potential serum marker for predicting the organ confined versus nonorgan confined growth of prostate cancer, J UROL, 163(5), 2000, pp. 1491-1497
Authors:
Graefen, M
Noldus, J
Pichlmeier, U
Haese, A
Hammerer, P
Fernandez, S
Conrad, S
Henke, RP
Huland, E
Huland, H
Citation: M. Graefen et al., Early prostate-specific antigen relapse after radical retropubic prostatectomy: Prediction on the basis of preoperative and postoperative tumor characteristics, EUR UROL, 36(1), 1999, pp. 21-30
Authors:
Haese, A
Huland, E
Graefen, M
Huland, H
Citation: A. Haese et al., Supersensitive PSA-analysis after radical prostatectomy: A powerful tool to reduce the time gap between surgery and evidence of biochemical failure, ANTICANC R, 19(4A), 1999, pp. 2641-2644
Authors:
Lilja, H
Haese, A
Bjork, T
Friedrich, MG
Piironen, T
Pettersson, K
Huland, E
Huland, H
Citation: H. Lilja et al., Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy, J UROL, 162(6), 1999, pp. 2029-2034
Authors:
Haese, A
Huland, E
Graefen, N
Hammerer, P
Noldus, J
Huland, H
Citation: A. Haese et al., Ultrasensitive detection of prostate specific antigen in the followup of 422 patients after radical prostatectomy, J UROL, 161(4), 1999, pp. 1206-1211
Risultati:
1-14
|